美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=ILOSONE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
ILOSONE SULFA 050599 001 NDA ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL SUSPENSION;ORAL EQ 125MG BASE/5ML;EQ 600MG BASE/5ML No No -- 1989/09/29 LILLY Discontinued
ILOSONE 050010 001 NDA ERYTHROMYCIN ESTOLATE SUSPENSION;ORAL EQ 125MG BASE/5ML No No 1967/04/13 Approved Prior to Jan 1, 1982 LILLY Discontinued
ILOSONE 050010 002 NDA ERYTHROMYCIN ESTOLATE SUSPENSION;ORAL EQ 250MG BASE/5ML No No 1967/04/13 Approved Prior to Jan 1, 1982 LILLY Discontinued
ILOSONE 061895 001 ANDA ERYTHROMYCIN ESTOLATE TABLET, CHEWABLE;ORAL EQ 125MG BASE No No 1975/01/03 Approved Prior to Jan 1, 1982 DISTA Discontinued
ILOSONE 061895 002 ANDA ERYTHROMYCIN ESTOLATE TABLET, CHEWABLE;ORAL EQ 250MG BASE No No 1975/01/03 Approved Prior to Jan 1, 1982 DISTA Discontinued
ILOSONE 061896 001 ANDA ERYTHROMYCIN ESTOLATE TABLET;ORAL EQ 500MG BASE No No 1975/01/03 Approved Prior to Jan 1, 1982 LILLY Discontinued
ILOSONE 061893 001 ANDA ERYTHROMYCIN ESTOLATE FOR SUSPENSION;ORAL EQ 125MG BASE/5ML No No 1975/01/06 Approved Prior to Jan 1, 1982 DISTA Discontinued
ILOSONE 061897 001 ANDA ERYTHROMYCIN ESTOLATE CAPSULE;ORAL EQ 125MG BASE No No 1975/01/06 Approved Prior to Jan 1, 1982 LILLY Discontinued
ILOSONE 061897 002 ANDA ERYTHROMYCIN ESTOLATE CAPSULE;ORAL EQ 250MG BASE No No 1975/01/06 Approved Prior to Jan 1, 1982 LILLY Discontinued
ILOSONE 061894 001 ANDA ERYTHROMYCIN ESTOLATE SUSPENSION;ORAL EQ 125MG BASE/5ML No No 1975/01/07 Approved Prior to Jan 1, 1982 LILLY Discontinued
ILOSONE 061894 002 ANDA ERYTHROMYCIN ESTOLATE SUSPENSION;ORAL EQ 250MG BASE/5ML No No 1975/01/07 Approved Prior to Jan 1, 1982 LILLY Discontinued
ILOSONE 061894 003 ANDA ERYTHROMYCIN ESTOLATE SUSPENSION/DROPS;ORAL EQ 100MG BASE/ML No No 1975/01/07 Approved Prior to Jan 1, 1982 LILLY Discontinued
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database